Literature DB >> 19238357

Do not use bisphosphonates without scientific evidence, neither in treatment nor prophylactic, in the treatment of stress fractures.

Ingrid Ekenman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19238357     DOI： 10.1007/s00167-009-0742-z

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN： 0942-2056            Impact factor:   4.342


× No keyword cloud information.
  16 in total

1.  Alendronate and risedronate: reports of severe bone, joint, and muscle pain.

Authors:  Diane K Wysowski; Jennie T Chang
Journal:  Arch Intern Med       Date:  2005-02-14

2.  Extracorporeal shock wave therapy for resistant stress fracture in athletes: a report of 5 cases.

Authors:  Masanori Taki; Osamu Iwata; Masaki Shiono; Masashi Kimura; Kenji Takagishi
Journal:  Am J Sports Med       Date:  2007-02-09       Impact factor: 6.202

Review 3.  The pathophysiology of stress fractures.

Authors:  Michelle Pepper; Venu Akuthota; Eric C McCarty
Journal:  Clin Sports Med       Date:  2006-01       Impact factor: 2.182

4.  Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate.

Authors:  Brett A Lenart; Dean G Lorich; Joseph M Lane
Journal:  N Engl J Med       Date:  2008-03-20       Impact factor: 91.245

5.  The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats.

Authors:  A H A Kurth; C Eberhardt; S Müller; M Steinacker; M Schwarz; F Bauss
Journal:  Bone       Date:  2005-08       Impact factor: 4.398

Review 6.  Bone microdamage and skeletal fragility in osteoporotic and stress fractures.

Authors:  D B Burr; M R Forwood; D P Fyhrie; R B Martin; M B Schaffler; C H Turner
Journal:  J Bone Miner Res       Date:  1997-01       Impact factor: 6.741

7.  Using bone's adaptation ability to lower the incidence of stress fractures.

Authors:  C Milgrom; A Simkin; A Eldad; M Nyska; A Finestone
Journal:  Am J Sports Med       Date:  2000 Mar-Apr       Impact factor: 6.202

8.  Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles.

Authors:  T Mashiba; C H Turner; T Hirano; M R Forwood; C C Johnston; D B Burr
Journal:  Bone       Date:  2001-05       Impact factor: 4.398

9.  Experimental stress fractures of the tibia. Biological and mechanical aetiology in rabbits.

Authors:  D B Burr; C Milgrom; R D Boyd; W L Higgins; G Robin; E L Radin
Journal:  J Bone Joint Surg Br       Date:  1990-05

Review 10.  A review of bone pain relief with ibandronate and other bisphosphonates in disorders of increased bone turnover.

Authors:  J D Ringe; J-J Body
Journal:  Clin Exp Rheumatol       Date:  2007 Sep-Oct       Impact factor: 4.473
View more
  2 in total

1.  Stress fractures: definition, diagnosis and treatment.

Authors:  Diego Costa Astur; Fernando Zanatta; Gustavo Gonçalves Arliani; Eduardo Ramalho Moraes; Alberto de Castro Pochini; Benno Ejnisman
Journal:  Rev Bras Ortop       Date:  2015-12-30

Review 2.  Is the Use of Bisphosphonates Putting Horses at Risk? An Osteoclast Perspective.

Authors:  Fernando B Vergara-Hernandez; Brian D Nielsen; Aimee C Colbath
Journal:  Animals (Basel)       Date:  2022-07-03       Impact factor: 3.231
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.